Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial.

Saved in:
Bibliographic Details
Title: Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial.
Authors: He M; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Jiang YZ; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Gong Y; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Fan L; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Liu XY; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Liu Y; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Tang LC; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Mo M; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Cancer Prevention and Clinical Statistics Center, Fudan University Shanghai Cancer Center, Shanghai, China., Hou YF; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Di GH; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Liu GY; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Yu KD; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Wu J; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Yan X; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Zeng XH; Breast Center, Chongqing Cancer Hospital, Chongqing University, Chongqing, China., Fu DY; Department of Thyroid and Breast Surgery, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China., Song CG; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China., Zhuang ZG; Department of Breast Surgery, Shanghai First Maternity and Infant Hospital, Shanghai Tongji University, Shanghai, China., Wu KJ; Department of Breast Surgery, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China., Wang J; Department of Breast Surgery, The International Peace Maternity and Child Health Hospital of China Welfare Institute, Shanghai Jiao Tong University, Shanghai, China., Wang ZH; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Shao ZM; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China zhimingshao@fudan.edu.cn.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Source: BMJ (Clinical research ed.) [BMJ] 2024 Oct 23; Vol. 387, pp. e079603. Date of Electronic Publication: 2024 Oct 23.
Publication Type: Journal Article; Clinical Trial, Phase III; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1756-1833
DOI:10.1136/bmj-2024-079603